Doctor profile · Federal record
Dr. Steven Smith, M.D. P.A.
Dermatology Physician (CMS: Dermatology) · Kingwood, TX
- NPI 1881687457
- Accepts Medicare
- MIPS 88.2 / 100 · 2023
- 51 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
19701 Kingwood Dr # 6
Kingwood, TX 773393772
(281) 359-6000
fax (281) 359-8006
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- May 3, 2012
- Year of graduation
- 1975 — 51 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #F-7619
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881687457. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,870
Distinct HCPCS
10
Medicare allowed
$463,235
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,636 | 597 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,754 | 1,051 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,054 | 717 | $49 | |
17110 |
Destruction of skin growth, 1-14 growths | 531 | 428 | $108 | |
11102 |
Biopsy of related skin growth, first growth | 528 | 422 | $89 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 199 | 170 | $55 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 166 | 118 | $165 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 161 | 46 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 154 | 106 | $49 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 150 | 150 | $108 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 295. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$1,626
Transactions
70
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 23 | $414.82 | |
| GENZYME CORPORATION | 9 | $250.95 | |
| Novartis Pharmaceuticals Corporation | 10 | $226.73 | |
| Journey Medical Corporation | 1 | $125.00 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $119.65 | |
| Amgen Inc. | 4 | $105.62 | |
| Janssen Biotech, Inc. | 4 | $90.76 | |
| Lilly USA, LLC | 4 | $84.67 | |
| REVANCE THERAPEUTICS, INC. | 2 | $68.36 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $48.86 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $48.10 | |
| Fidia Pharma USA Inc. | 1 | $14.43 | |
| Arcutis Biotherapeutics, Inc. | 1 | $14.03 | |
| ConvaTec Inc. | 1 | $13.55 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
556
Patients
284
Total drug cost
$111,193
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 83 | 68 | $1,245 |
| Ketoconazole | Generic | 64 | 25 | $932 |
| Mometasone Furoate | Generic | 55 | 34 | $1,497 |
| Doxycycline Hyclate | Generic | 54 | 28 | $1,269 |
| Fluorouracil | Generic | 51 | 48 | $4,143 |
| Clobetasol Propionate | Generic | 47 | 26 | $3,183 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 45 | 15 | $1,771 |
| Mupirocin | Generic | 31 | 27 | $262 |
| Spironolactone | Generic | 28 | 0 | $868 |
| Otezla (Apremilast) | Brand | 22 | 0 | $87,141 |
Frequently asked questions
What is Dr. Steven Smith's medical specialty?
Dr. Steven Smith practices Dermatology Physician in Kingwood, TX.
Where does Dr. Steven Smith practice?
Dr. Steven Smith practices at 19701 Kingwood Dr # 6, Kingwood, TX 773393772. Office phone: 2813596000.
What is Dr. Steven Smith's NPI?
Dr. Steven Smith's National Provider Identifier (NPI) is 1881687457, issued by NPPES.
Does Dr. Steven Smith accept Medicare assignment?
Yes. Dr. Steven Smith accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Steven Smith commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.